share_log
Breakings ·  Oct 27 07:30
Vera Therapeutics Inc - Trial Met Primary and Secondary Endpoints With Significant Proteinuria Reductions
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment